|Articles|October 26, 2012
Health Ingredients Europe Sneak Peek: Staving Off Postprandial Blood Glucose Spikes
Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals.
Advertisement
Wacker offers a soluble dietary fiber that is scientifically proven and acknowledged by EFSA to have a significant effect on reducing postprandial glycaemic response. This fiber, branded under the trademark Cavamax W6, is an alpha-cyclodextrin, a carbohydrate enzymatically derived from starch. Clinical trials show that consumption of Cavamax W6 can contribute to the reduction of the blood glucose rise that occurs after starch-containing meals. Further clinical trials show a positive effect of Cavamax W6 on blood lipid levels. Cavamax W6 is highly stable in heat and acidic conditions, is non-hygroscopic and non-browning, and is ideally suited for beverage applications.
Booth C46
Newsletter
From ingredient science to consumer trends, get the intel you need to stay competitive in the nutrition space—subscribe now to Nutritional Outlook.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
New food app leverages AI to help consumers understand ingredients right from grocery aisle
2
How Aged Garlic Extract is Changing Men's Vitality
3
Greenvit joins the collagen ingredient market
4
SAI Gold level status received by Layn Natural ingredients for monk fruit
5
